BIO CEO 2022: How Incubators Enable Biotech Startups
At a panel discussion at the BIO CEO 2022, leaders from the top incubators shared their insights into how they identify new technology, what kind of assistance they can provide and what entrepreneurs need to prioritize to succeed. The session was hosted by Chris Garabedian, Chairman and CEO of Xontogeny with participation from:
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115